Non-small cell lung cancer: from targeted therapy to tailored therapy

被引：3
作者：
Malgieri, Simona [1 ]
Feliciano, Salvatore
Bosso, Davide
Federico, Piera
Palmieri, Giovannella
De Placido, Sabino
Di Lorenzo, Giuseppe
Buonerba, Carlo
机构：
[1] Univ Naples Federico II, Genitourinary Canc Sect, Naples, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2012年 / 13卷 / 13期
关键词：
bevacizumab; lung cancer; tailored therapy; targeted therapy; PHASE-III TRIAL; RANDOMIZED TRIAL; 1ST-LINE THERAPY; BEVACIZUMAB; CISPLATIN; CHEMOTHERAPY; ETOPOSIDE; REGIMENS;
D O I：
10.1517/14656566.2012.707645
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1817 / 1819
页数：3
相关论文
共 16 条
  • [1] Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
    Correale, Pierpaolo
    Botta, Cirino
    Basile, Assunta
    Pagliuchi, Marco
    Licchetta, Antonella
    Martellucci, Ignazio
    Bestoso, Elena
    Apollinari, Serena
    Addeo, Raffaele
    Misso, Gabriella
    Romano, Ornella
    Abbruzzese, Alberto
    Lamberti, Monica
    Luzzi, Luca
    Gotti, Giuseppe
    Rotundo, Maria Saveria
    Caraglia, Michele
    Tagliaferri, Pierosandro
    [J]. CANCER BIOLOGY & THERAPY, 2011, 12 (02) : 112 - 118
  • [2] Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients
    Correale, Pierpaolo
    Remondo, Cinzia
    Carbone, Salvatore Francesco
    Ricci, Veronica
    Migali, Cristina
    Martellucci, Ignazio
    Licchetta, Antonella
    Addeo, Raffaele
    Volterrani, Luca
    Gotti, Giuseppe
    Rotundo, Maria Saveria
    Tassone, Pierfrancesco
    Sperlongano, Pasquale
    Abbruzzese, Alberto
    Caraglia, Michele
    Tagliaferri, Pierosandro
    Francini, Guido
    [J]. CANCER BIOLOGY & THERAPY, 2010, 9 (09) : 685 - 693
  • [3] A RANDOMIZED TRIAL OF 3 CISPLATIN-CONTAINING REGIMENS IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A STUDY OF THE UMBRIAN-LUNG-CANCER-GROUP
    CRINO, L
    TONATO, M
    DARWISH, S
    MEACCI, ML
    CORGNA, E
    DICOSTANZO, F
    BUZZI, F
    FORNARI, G
    SANTI, E
    BALLATORI, E
    SANTUCCI, C
    DAVIS, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (01) : 52 - 56
  • [4] Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
    Dediu, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1345 - 1347
  • [5] Dediu M, 2004, J CONTRACEPT FERTIL, V22, P1347
  • [6] Toxicities of Targeted Therapy and Their Management in Kidney Cancer
    Di Lorenzo, Giuseppe
    Porta, Camillo
    Bellmunt, Joaquim
    Sternberg, Cora
    Kirkali, Ziya
    Staehler, Michael
    Joniau, Steven
    Montorsi, Francesco
    Buonerba, Carlo
    [J]. EUROPEAN UROLOGY, 2011, 59 (04) : 526 - 540
  • [7] Non Small Cell Lung Cancer
    Ettinger, David S.
    Akerley, Wallace
    Bepler, Gerold
    Blum, Matthew G.
    Chang, Andrew
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Ganti, Apar Kishor P.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Jahan, Thierry
    Jahanzeb, Mohammad
    Johnson, David H.
    Kessinger, Anne
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Le, Quynh-Thu
    Lennes, Inga T.
    Martins, Renato
    O'Malley, Janis
    Osarogiagbon, Raymond U.
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Simon, George R.
    Swanson, Scott J.
    Wood, Douglas E.
    Yang, Stephen C.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (07): : 740 - +
  • [8] HANG XF, 2011, WELSH PAED J, V67, P613, DOI DOI 10.1007/S00228-010-0988-X
  • [9] First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naive patients
    Leon, Luis
    Vazquez, Sergio
    Manuel Gracia, Jose
    Casal, Joaquin
    Lazaro, Martin
    Luis Firvida, Jose
    Amenedo, Margarita
    Santome, Lucia
    Macia, Sonia
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1389 - 1396
  • [10] Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
    Pirker, Robert
    Pereira, Jose R.
    Szczesna, Aleksandra
    von Pawel, Joachim
    Krzakowski, Maciej
    Ramlau, Rodryg
    Vynnychenko, Ihor
    Park, Keunchil
    Yu, Chih-Teng
    Ganul, Valentyn
    Roh, Jae-Kyung
    Bajetta, Emilio
    O'Byrne, Kenneth
    de Marinis, Filippo
    Eberhardt, Wilfried
    Goddemeier, Thomas
    Emig, Michael
    Gatzemeier, Ulrich
    Pirker, R.
    Thatcher, N.
    Armand, J. P.
    Camus, P.
    Victor, N.
    Emig, M.
    Mueser, M.
    Pilz, K.
    Goddemeier, T.
    Montaner, I.
    Lachs, Martin
    Hoang-Sayag, Loan
    Alvarez, A.
    Coppola, F.
    Recondo, G.
    Richardet, E.
    Kirsten, F.
    Karapetis, C.
    Parente, P.
    Michael, M.
    White, S.
    Boyce, A.
    Lewis, C.
    Slancar, M.
    Pavlakis, N.
    Abdi, E.
    Underhill, C.
    Pittman, K.
    Burghuber, O.
    Pirker, R.
    Ruckser, R.
    Ulsperger, E.
    [J]. LANCET, 2009, 373 (9674) : 1525 - 1531
12